DNMT3b also exhibited a 4-fold increase of expression in HCC when compared to healthy livers, which correlated with poorer prognosis [21], which corroborates assumptions that DNMT3 subtypes become overexpressed in cancer after having been downregulated postcellular differentiation [22]. The gene discussed is DNMT3B; the disease is hepatocellular carcinoma.